Purchase Order HHSN268201500056P
Award Date 7/31/15
Potential Completion Date 8/13/16
Potential Value $167K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $18,371.00 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is for the NHLBI's DIR Graft Lungevity Study, which requires obtaining samples and data. The contract has an ultimate completion date of August 31, 2025 and was awarded on September...
- This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian federal agency, to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $12,427,447.18 contract is for a randomized clinical trial of genotype-guided dosing of warfarin therapy. The contract does not have a set-aside designation, reflecting the University of Pennsylvania's status as a large research...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health to the Trustees of the University of Pennsylvania, operating as the University of Pennsylvania, to conduct biomedical research, data analysis, and other scientific activities supporting public health objectives. The $885,000.00 contract is a definitive contract with a time and materials pricing type, with a completion date of March 15, 2005. The contract does not have a set-aside...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Delivery Order to The Trustees of the University of Pennsylvania (Penn) on August 23, 2019 with a potential value of $1,408,152.00 for "TASK AREA B: PRE-CLINICAL VECTOR CORE LABORATORY SCIENTIFIC ACTIVITIES" under the Gene Therapy Resource Program (GTRP). This is a Cost No Fee contract with a completion date of September 22, 2021. Penn is a private university...
- This is a purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $6,870 firm-fixed-price contract is for laboratory support services to analyze human cerebrospinal fluid and plasma samples from a National Institute on Aging (NIA) clinical trial evaluating the use of...
- This $14,424.00 firm fixed-price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The award, which does not have a set-aside designation, is described as QTE#27207 and has an ultimate completion date of August 11, 2023. The University of Pennsylvania is a renowned private...
- This is a $16,000 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is not set-aside and is for "other functions" in support of NIAID's mission. Penn is a renowned private research university and academic medical center that has a long history of conducting cutting-edge research...
- This is a $8,000 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is for the University of Pennsylvania to provide unspecified "other functions" and was not set aside for any socioeconomic program. The University of Pennsylvania is...
- The Trustees of the University of Pennsylvania, operating as the University of Pennsylvania, was awarded a $351,000.00 cost-plus-award-fee contract by a U.S. government agency to provide biomedical research, data analysis, and other scientific support services. As a private university and non-profit organization, the University of Pennsylvania has extensive experience conducting research across disciplines including medicine, engineering, and the sciences on behalf of federal sponsors such as...
- This federal contract award was issued by the Food and Drug Administration (FDA) to The Trustees of The University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, for a firm fixed-price delivery order. The contract, valued at $1,268.22, is to provide expertise and support for communications and an annual meeting related to the FDA's epidemiology research. The contract has no set-aside designation. The University of Pennsylvania is a prestigious private...
The University of Pennsylvania has been awarded a $166,701.58 firm fixed-price purchase order contract by the National Heart, Lung, and Blood Institute (NHLBI) to provide scientific support services for the Framingham Walking Study pilot program. The contract does not have a set-aside designation. As a renowned private research university, the University of Pennsylvania has a long history of conducting cutting-edge research and delivering high-quality services to federal agencies, including the National Institutes of Health. Through this contract, the university will support NHLBI's research objectives by providing scientific expertise and services related to the Framingham Walking Study, which aims to advance medical research.
Generated 4/3/25, 2:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Close Out | ($23) | 9/12/18 | |
| Not listed | Not listed | $166.7k | 7/31/15 |